Technology
Health
Biotechnology

Vaxart

$0.69
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0199 (-2.84%) Today
+$0.01 (1.47%) After Hours

Why Robinhood?

You can buy or sell Vaxart and other stocks, options, ETFs, and crypto commission-free!

About

Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. Read More The company was founded in 2004 and is headquartered in South San Francisco, CA.

Employees
34
Headquarters
South San Francisco, California
Founded
2004
Market Cap
5.67M
Price-Earnings Ratio
โ€”
Dividend Yield
0.00
Average Volume
400.79K
High Today
$0.713
Low Today
$0.678
Open Price
$0.70
Volume
27.28K
52 Week High
$7.60
52 Week Low
$0.6049

Collections

Technology
Health
Biotechnology
Medical
US
North America

News

Yahoo FinanceMay 9

Vaxart Announces First Quarter 2019 Financial Results and Provides Corporate Update

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- - $13 million raised in 1H19 - - Norovirus bivalent vaccine Phase 1b clinical study underway with results expected in 2H19 - Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced financial results for the first quarter ended March 31, 2019. โ€œWith the Phase 1b study of our bivalent norovirus tablet vaccine underway and two successful financings behin...

353
Yahoo FinanceMay 7

Have Insiders Been Buying Vaxart, Inc. (NASDAQ:VXRT) Shares?

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is that there are more than a few examples of insiders dumping stock prior to a period of weak performance. So shareholders might well want to know whether insiders have been buying or selling shares in Vaxart, Inc. (NASDAQ:VXRT). What Is Insider Buying? It's quite normal ...

271

Earnings

-$1.24
-$0.89
-$0.53
-$0.18
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
โ€”
Actual
Expected Aug 8, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.